Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death
S R Cerda1, R Mustafi, H Little
1Department of Medicine, Division of Gastroenterology, University of Chicago, Chicago, IL 60637, USA. scerda@medicine.bsd.uchicago.edu
Abstract:
PKC-delta is a serine/threonine kinase that mediates diverse signal transduction pathways. We previously demonstrated that overexpression of PKC-delta slowed the G1 progression of Caco-2 colon cancer cells, accelerated apoptosis, and induced cellular differentiation. In this study, we further characterized the PKC-delta dependent signaling pathways involved in these tumor suppressor actions in Caco-2 cells overexpressing PKC-delta using a Zn2+ inducible expression vector. Consistent with a G1 arrest, increased expression of PKC-delta caused rapid and significant downregulation of cyclin D1 and cyclin E proteins (50% decreases, P<0.05), while mRNA levels remained unchanged. The PKC agonist, phorbol 12-myristate 13-acetate (TPA, 100 nM, 4 h), induced two-fold higher protein and mRNA levels of p21(Waf1), a cyclin-dependent kinase (cdk) inhibitor in PKC-delta transfectants compared with empty vector (EV) transfected cells, whereas the PKC-delta specific inhibitor rottlerin (3 microM) or knockdown of this isoenzyme with specific siRNA oligonucleotides blocked p21(Waf1) expression. Concomitantly, compared to EV control cells, PKC-delta upregulation decreased cyclin D1 and cyclin E proteins co-immunoprecipitating with cdk6 and cdk2, respectively. In addition, overexpression of PKC-delta increased binding of cdk inhibitor p27(Kip1) to cdk4. These alterations in cyclin-cdks and their inhibitors are predicted to decrease G1 cyclin kinase activity. As an independent confirmation of the direct role PKC-delta plays in cell growth and cell cycle regulation, we knocked down PKC-delta using specific siRNA oligonucleotides. PKC-delta specific siRNA oligonucleotides, but not irrelevant control oligonucleotides, inhibited PKC-delta protein by more than 80% in Caco-2 cells. Moreover, PKC-delta knockdown enhanced cell proliferation ( approximately 1.4-2-fold, P<0.05) and concomitantly increased cyclin D1 and cyclin E expression ( approximately 1.7-fold, P<0.05). This was a specific effect, as nontargeted PKC-zeta was not changed by PKC-delta siRNA oligonucleotides. Consistent with accelerated apoptosis in PKC-delta transfectants, compared to EV cells, PKC-delta upregulation increased proapoptotic regulator Bax two-fold at mRNA and protein levels, while antiapoptotic Bcl-2 protein was decreased by 50% at a post-transcriptional level. PKC-delta specific siRNA oligonucleotides inhibited Bax protein expression by more than 50%, indicating that PKC-delta regulates apoptosis through Bax. Taken together, these results elucidate two critical mechanisms regulated by PKC-delta that inhibit cell cycle progression and enhance apoptosis in colon cancer cells. We postulate these antiproliferative pathways mediate an important tumor suppressor function for PKC-delta in colonic carcinogenesis.
Insights
Protein kinase C-delta (PKC-delta) inhibits colon cancer cell growth by slowing cell cycle progression and promoting apoptosis. This study elucidates PKC-delta
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Protein kinase C-delta (PKC-delta) is a serine/threonine kinase involved in various signaling pathways.
- Previous studies indicated PKC-delta overexpression slows G1 progression, accelerates apoptosis, and induces differentiation in Caco-2 colon cancer cells.
Purpose of the Study:
- To further characterize the specific signaling pathways by which PKC-delta exerts its tumor suppressor functions in Caco-2 colon cancer cells.
- To investigate the role of PKC-delta in regulating cell cycle progression and apoptosis.
Main Methods:
- Utilized a Zn2+ inducible expression vector to overexpress PKC-delta in Caco-2 cells.
- Employed Western blotting, quantitative PCR, and co-immunoprecipitation to analyze protein and mRNA levels of cyclins, cyclin-dependent kinase (cdk) inhibitors, and apoptosis regulators.
- Used small interfering RNA (siRNA) to specifically knock down PKC-delta expression and assess its effects on cell proliferation and apoptosis.
Main Results:
- PKC-delta overexpression significantly downregulated cyclin D1 and cyclin E protein levels, leading to G1 cell cycle arrest.
- PKC-delta upregulated the expression of p21(Waf1), a cdk inhibitor, and increased the binding of p27(Kip1) to cdk4, further inhibiting G1 kinase activity.
- Knockdown of PKC-delta using siRNA enhanced cell proliferation and increased cyclin D1 and cyclin E expression, confirming its antiproliferative role.
- PKC-delta overexpression increased the pro-apoptotic regulator Bax and decreased the anti-apoptotic protein Bcl-2, promoting apoptosis.
- PKC-delta knockdown inhibited Bax protein expression, indicating its role in regulating apoptosis.
Conclusions:
- PKC-delta inhibits colon cancer cell proliferation by suppressing G1 cell cycle progression through modulation of cyclin/cdk complexes and their inhibitors.
- PKC-delta promotes apoptosis in colon cancer cells by regulating the expression of Bax and Bcl-2.
- These findings elucidate critical antiproliferative mechanisms mediated by PKC-delta, highlighting its significant tumor suppressor function in colon carcinogenesis.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...


